Firsts Home

Equity & Derivatives Companies, sectors, M&A and the financial industry
Reuters scoops OK for GW cannabis drug; shares jump 06.18.2010 Reuters scooped on June 18 that UK regulators had granted a licence to GW Pharma`s closely watched cannabis drug Sativex. Shares in the British drugmaker jumped 11 percent to a four-year high on the news, which was confirmed 83 minutes later in a stock exchange statement from the company. The Reuters story was based on a conversation with an official at the Medicines and Healthcare products Regulatory Agency. Reuters Firsts will need at least flash player 9 to give you the full experience. The latest Flash player can be downloaded here	firsts across any industry Commodities & Energy Energy, metals, agricultural and environmental markets FX & Money Markets Macroeconomics, monetary policy, FX and money markets Politics & Risk Politics and political risk Equity & Derivatives Companies, sectors, M&A and the financial industry Fixed Income Sovereign and corporate debt, credit, and ratings firsts by region Americas View stories from this region Europe / Middle East / Africa View stories from this region Asia View stories from this region Emerging Markets View stories from this region

Equity & Derivatives

Companies, sectors, M&A and the financial industry

Reuters scoops OK for GW cannabis drug; shares jump

06.18.2010

Reuters scooped on June 18 that UK regulators had granted a licence to GW Pharma`s closely watched cannabis drug Sativex. Shares in the British drugmaker jumped 11 percent to a four-year high on the news, which was confirmed 83 minutes later in a stock exchange statement from the company. The Reuters story was based on a conversation with an official at the Medicines and Healthcare products Regulatory Agency.

Reuters Firsts will need at least flash player 9 to give you the full experience. The latest Flash player can be downloaded here